Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 49
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Perna, Giampaolo Alciati, Alessandra Riva, Alice Micieli, Wilma and Caldirola, Daniela 2016. Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review. Current Psychiatry Reports, Vol. 18, Issue. 3,


    Zhang, Yuhai Zhou, Xiao-hua Meranus, Dana H. Wang, Linbo and Kukull, Walter A. 2016. Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition. Alzheimer Disease & Associated Disorders, Vol. 30, Issue. 2, p. 113.


    Billioti de Gage, Sophie Pariente, Antoine and Bégaud, Bernard 2015. Is there really a link between benzodiazepine use and the risk of dementia?. Expert Opinion on Drug Safety, Vol. 14, Issue. 5, p. 733.


    Bourgeois, Jolyce Elseviers, Monique M. Van Bortel, Luc Petrovic, Mirko and Vander Stichele, Robert H. 2015. The impact of chronic benzodiazepine use on cognitive evolution in nursing home residents. Human Psychopharmacology: Clinical and Experimental, Vol. 30, Issue. 2, p. 85.


    Feuillet, Fanny Bellanger, Lise Hardouin, Jean-Benoit Victorri-Vigneau, Caroline and Sébille, Véronique 2015. On Comparison of Clustering Methods for Pharmacoepidemiological Data. Journal of Biopharmaceutical Statistics, Vol. 25, Issue. 4, p. 843.


    Ivanets, N. N. Kinkulkina, M. A. Avdeeva, T. I. and Sysoeva, V. P. 2015. Remote consequences of the long-term uncontrolled use of anxiolytic and hypnotic drugs by elderly patients: cognitive disorders. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, Vol. 115, Issue. 12, p. 50.


    Shih, Hsin-I Lin, Che-Chen Tu, Yi-Fang Chang, Chia-Ming Hsu, Hsiang-Chin Chi, Chih-Hsien and Kao, Chia-Hung 2015. An Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population. Medicine, Vol. 94, Issue. 17, p. e809.


    Arora, Amit O'Neill, Andrew Crome, Peter and Martin, Finbarr C. 2014. Substance Use and Older People.


    Bourgeois, J. Elseviers, M.M. Azermai, M. Van Bortel, L. Petrovic, M. and Vander Stichele, R.R. 2014. Barriers to discontinuation of chronic benzodiazepine use in nursing home residents: Perceptions of general practitioners and nurses. European Geriatric Medicine, Vol. 5, Issue. 3, p. 181.


    Hsiao, Fei-Yuan Peng, Li-Ning Lin, Ming-Hsien and Chen, Liang-Kung 2014. Dose-Responsive Effect of Psychotropic Drug Use and Subsequent Dementia: A Nationwide Propensity Score Matched Case-Control Study in Taiwan. Journal of the American Medical Directors Association, Vol. 15, Issue. 7, p. 509.


    Lader, Malcolm 2014. Benzodiazepine harm: how can it be reduced?. British Journal of Clinical Pharmacology, Vol. 77, Issue. 2, p. 295.


    Murphy, Kevin Daniel Byrne, Stephen McCarthy, Suzanne Lambert, Sharon and Sahm, Laura Jane 2014. Benzodiazepine Use Among Young Attendees of an Irish Substance Treatment Center. Journal of Addiction Medicine, Vol. 8, Issue. 3, p. 199.


    2014. Management of non-cognitive symptoms associated with dementia. Drug and Therapeutics Bulletin, Vol. 52, Issue. 10, p. 114.


    Azermai, Majda Bourgeois, Jolyce Somers, Annemie and Petrovic, Mirko 2013. Inappropriate use of psychotropic drugs in older individuals: implications for practice. Aging Health, Vol. 9, Issue. 3, p. 255.


    Dell’osso, B. and Lader, M. 2013. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. European Psychiatry, Vol. 28, Issue. 1, p. 7.


    Koyama, Alain Steinman, Michael Ensrud, Kristine Hillier, Teresa A. and Yaffe, Kristine 2013. Ten-Year Trajectory of Potentially Inappropriate Medications in Very Old Women: Importance of Cognitive Status. Journal of the American Geriatrics Society, Vol. 61, Issue. 2, p. 258.


    Mura, Thibault Proust-Lima, Cécile Akbaraly, Tasnime Amieva, Hélène Tzourio, Christophe Chevassus, Hugues Picot, Marie-Christine Jacqumin-Gadda, Hélène and Berr, Claudine 2013. Chronic use of benzodiazepines and latent cognitive decline in the elderly: Results from the Three-city study. European Neuropsychopharmacology, Vol. 23, Issue. 3, p. 212.


    Obermann, Karen R. Morris, John C. and Roe, Catherine M. 2013. Exploration of 100 commonly used drugs and supplements on cognition in older adults. Alzheimer's & Dementia, Vol. 9, Issue. 6, p. 724.


    Bourgeois, Jolyce Elseviers, Monique M. Azermai, Majda Van Bortel, Luc Petrovic, Mirko and Vander Stichele, Robert R. 2012. Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages. European Journal of Clinical Pharmacology, Vol. 68, Issue. 5, p. 833.


    Cheng, Kao-Chi Chen, Yu-Lung Lai, Shih-Wei Mou, Chih-Hsin Tsai, Pang-Yao and Sung, Fung-Chang 2012. Patients with chronic kidney disease are at an elevated risk of dementia: A population-based cohort study in Taiwan. BMC Nephrology, Vol. 13, Issue. 1,


    ×

Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies

  • HELENE VERDOUX (a1), RAJAA LAGNAOUI (a1) and BERNARD BEGAUD (a1)
  • DOI: http://dx.doi.org/10.1017/S0033291704003897
  • Published online: 01 April 2005
Abstract

Background. A major public health issue is to determine whether long-term benzodiazepine use may induce cognitive deficits persisting after withdrawal. The aim of the present review was to examine findings from prospective studies carried out in general population samples exploring whether exposure to benzodiazepines is associated with an increased risk of incident cognitive decline.

Method. Using a MEDLINE search and a hand-search of related references in selected papers, we retrieved original studies published in peer-reviewed journals that explored in general population samples the association between benzodiazepine exposure and change in cognitive performance between baseline and follow-up assessment.

Results. Six papers met the inclusion criteria. Two studies reported a lower risk of cognitive decline in former or ever users, two found no association whatever the category of user, and three found an increased risk of cognitive decline in benzodiazepine users.

Conclusions. The discrepant findings obtained by studies examining the link between benzodiazepine exposure and risk of cognitive decline may be due to methodological differences, especially regarding the definitions of exposure and cognitive outcome. As a large proportion of subjects are exposed to benzodiazepines, a small increase in the risk of cognitive decline may have marked deleterious consequences for the health of the general population. This issue needs to be explored further by pharmaco-epidemiological studies.

Copyright
Corresponding author
Professeur Hélène Verdoux, Hôpital Charles Perrens, 121 rue de la Béchade, 33076 Bordeaux Cedex, France. (Email: helene.verdoux@u-bordeaux2.fr)
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×